Skip to main content

Table 1 Main clinical features

From: Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!

Total patients 103
Male (%) 66 (64%)
Age (years), mean (± SD) 60.3 (±13.1)
Axonal sensory-motor polyneuropathy (%) 48 (46.6%)
Axonal sensory polyneuropathy (%) 45 (43.7%)
Demyelinating neuropathy (%) 10 (9.7%)
Sensory symptoms (%) 85 (82.5%)
Motor symptoms (%) 51 (49.5%)
Small fiber neuropathy (%) 5 (4.8%)
α-GAL A activity in males (mean (± SD) 26.4 nmol/L/h (± 12.6)
Patients with systemic symptoms or signs of FD (%) 9 (8.7%)